| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 PREPL GZMB TMPRSS2 HABP2 CTRL CTSG CTSH TPSB2 | 3.01e-12 | 190 | 217 | 18 | GO:0004252 |
| GeneOntologyMolecularFunction | endopeptidase activity | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 USP11 ADAM10 ST14 C1R SPPL2C TMPRSS9 CASP2 KLK14 PREPL USP6 GZMB TMPRSS2 PAPPA HABP2 CTRL ESPL1 CTSG CTSH TPSB2 | 9.45e-12 | 430 | 217 | 25 | GO:0004175 |
| GeneOntologyMolecularFunction | serine-type peptidase activity | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 PREPL GZMB TMPRSS2 HABP2 CTRL CTSG CTSH TPSB2 | 1.28e-11 | 207 | 217 | 18 | GO:0008236 |
| GeneOntologyMolecularFunction | serine hydrolase activity | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 PREPL GZMB TMPRSS2 HABP2 CTRL CTSG CTSH TPSB2 | 1.92e-11 | 212 | 217 | 18 | GO:0017171 |
| GeneOntologyMolecularFunction | peptidase activity | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 USP11 ADAM10 ST14 C1R SPPL2C TMPRSS9 CASP2 KLK14 PREPL USP6 GZMB TMPRSS2 PAPPA HABP2 CTRL ESPL1 CTSG CTSH TPSB2 | 5.20e-08 | 654 | 217 | 25 | GO:0008233 |
| GeneOntologyMolecularFunction | ATPase inhibitor activity | 2.47e-05 | 6 | 217 | 3 | GO:0042030 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.48e-04 | 52 | 217 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | ZBTB38 ZNF174 ADAM10 HESX1 KMT2A NOS2 SPPL2C MTUS2 FLNA COL9A1 GOPC UGT1A5 SLC26A5 RNF8 BCAS1 UGT1A4 TENM4 TENM3 APPL1 RAB11FIP3 | 6.04e-04 | 815 | 217 | 20 | GO:0042803 |
| GeneOntologyCellularComponent | external encapsulating structure | TPSAB1 PRSS2 ADAM10 FCN1 LRRTM4 NAV2 COL9A1 COL12A1 TECTA PKHD1L1 EMILIN1 ENAM SNED1 LTBP1 CTSG CTSH AGRN TPSB2 | 1.97e-04 | 658 | 218 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | sodium channel complex | 2.23e-04 | 29 | 218 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | activating signal cointegrator 1 complex | 3.23e-04 | 3 | 218 | 2 | GO:0099053 | |
| GeneOntologyCellularComponent | extracellular matrix | TPSAB1 PRSS2 ADAM10 FCN1 LRRTM4 NAV2 COL9A1 COL12A1 TECTA EMILIN1 ENAM SNED1 LTBP1 CTSG CTSH AGRN TPSB2 | 5.48e-04 | 656 | 218 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | TRPM5 CLIC5 CLCN7 SCN1A SCN3A SCN4A LRRTM4 AKAP6 CACNA2D1 GRIK4 SLCO6A1 KCNH5 | 6.48e-04 | 378 | 218 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.83e-04 | 17 | 218 | 3 | GO:0001518 | |
| Domain | TRYPSIN_SER | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 4.74e-15 | 90 | 213 | 16 | IPR033116 |
| Domain | TRYPSIN_HIS | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 4.35e-14 | 103 | 213 | 16 | IPR018114 |
| Domain | TRYPSIN_SER | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 6.94e-14 | 106 | 213 | 16 | PS00135 |
| Domain | TRYPSIN_HIS | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 8.08e-14 | 107 | 213 | 16 | PS00134 |
| Domain | Peptidase_S1A | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 1.95e-13 | 113 | 213 | 16 | IPR001314 |
| Domain | TRYPSIN_DOM | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 2.58e-13 | 115 | 213 | 16 | PS50240 |
| Domain | Tryp_SPc | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 3.39e-13 | 117 | 213 | 16 | SM00020 |
| Domain | Trypsin_dom | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 5.79e-13 | 121 | 213 | 16 | IPR001254 |
| Domain | Trypsin | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 5.79e-13 | 121 | 213 | 16 | PF00089 |
| Domain | Peptidase_S1_PA | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 PRSS38 ST14 C1R TMPRSS9 KLK14 GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 7.51e-13 | 123 | 213 | 16 | IPR009003 |
| Domain | CUB | 1.90e-05 | 49 | 213 | 6 | PF00431 | |
| Domain | CUB | 2.14e-05 | 50 | 213 | 6 | SM00042 | |
| Domain | - | 2.70e-05 | 52 | 213 | 6 | 2.60.120.290 | |
| Domain | CUB | 3.01e-05 | 53 | 213 | 6 | PS01180 | |
| Domain | CUB_dom | 4.58e-05 | 57 | 213 | 6 | IPR000859 | |
| Domain | EGF | HGFAC ITGB5 STAB1 C1R TECTA SNED1 TENM4 TENM3 HABP2 LTBP1 AGRN | 8.43e-05 | 235 | 213 | 11 | SM00181 |
| Domain | EGF | 9.96e-05 | 126 | 213 | 8 | PF00008 | |
| Domain | PUFD | 1.29e-04 | 2 | 213 | 2 | IPR032365 | |
| Domain | FNIP_N_dom | 1.29e-04 | 2 | 213 | 2 | IPR028084 | |
| Domain | FNIP_mid_dom | 1.29e-04 | 2 | 213 | 2 | IPR028085 | |
| Domain | FNIP_C_dom | 1.29e-04 | 2 | 213 | 2 | IPR028086 | |
| Domain | FNIP_C | 1.29e-04 | 2 | 213 | 2 | PF14638 | |
| Domain | FNIP_M | 1.29e-04 | 2 | 213 | 2 | PF14637 | |
| Domain | FNIP_N | 1.29e-04 | 2 | 213 | 2 | PF14636 | |
| Domain | FNIP_fam | 1.29e-04 | 2 | 213 | 2 | IPR026156 | |
| Domain | PUFD | 1.29e-04 | 2 | 213 | 2 | PF16553 | |
| Domain | BCOR | 1.29e-04 | 2 | 213 | 2 | PF15808 | |
| Domain | BCOR | 1.29e-04 | 2 | 213 | 2 | IPR031628 | |
| Domain | Na_channel_asu | 1.65e-04 | 10 | 213 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.65e-04 | 10 | 213 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.65e-04 | 10 | 213 | 3 | PF06512 | |
| Domain | OA_transporter | 2.98e-04 | 12 | 213 | 3 | IPR004156 | |
| Domain | OATP | 2.98e-04 | 12 | 213 | 3 | PF03137 | |
| Domain | CCP | 3.70e-04 | 54 | 213 | 5 | SM00032 | |
| Domain | Rhs_assc_core | 3.85e-04 | 3 | 213 | 2 | IPR022385 | |
| Domain | - | 3.85e-04 | 3 | 213 | 2 | 1.10.10.430 | |
| Domain | PP2C_C | 3.85e-04 | 3 | 213 | 2 | PF07830 | |
| Domain | ASD1 | 3.85e-04 | 3 | 213 | 2 | PF08688 | |
| Domain | ASD1_dom | 3.85e-04 | 3 | 213 | 2 | IPR014800 | |
| Domain | PP2C_C | 3.85e-04 | 3 | 213 | 2 | IPR012911 | |
| Domain | ASD1 | 3.85e-04 | 3 | 213 | 2 | PS51306 | |
| Domain | SUSHI | 4.38e-04 | 56 | 213 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 4.76e-04 | 57 | 213 | 5 | IPR000436 | |
| Domain | PP2C_SIG | 4.85e-04 | 14 | 213 | 3 | SM00331 | |
| Domain | EGF-like_dom | 5.97e-04 | 249 | 213 | 10 | IPR000742 | |
| Domain | PPM_1 | 6.01e-04 | 15 | 213 | 3 | PS01032 | |
| Domain | EGF_1 | 7.17e-04 | 255 | 213 | 10 | PS00022 | |
| Domain | Kazal_2 | 7.28e-04 | 36 | 213 | 4 | PF07648 | |
| Domain | AT_hook | 7.34e-04 | 16 | 213 | 3 | PF02178 | |
| Domain | Tox-GHH_dom | 7.65e-04 | 4 | 213 | 2 | IPR028916 | |
| Domain | Tox-GHH | 7.65e-04 | 4 | 213 | 2 | PF15636 | |
| Domain | Shroom_fam | 7.65e-04 | 4 | 213 | 2 | IPR027685 | |
| Domain | ASD2_dom | 7.65e-04 | 4 | 213 | 2 | IPR014799 | |
| Domain | ASD2 | 7.65e-04 | 4 | 213 | 2 | PF08687 | |
| Domain | Ten_N | 7.65e-04 | 4 | 213 | 2 | IPR009471 | |
| Domain | Ten_N | 7.65e-04 | 4 | 213 | 2 | PF06484 | |
| Domain | TENEURIN_N | 7.65e-04 | 4 | 213 | 2 | PS51361 | |
| Domain | ASD2 | 7.65e-04 | 4 | 213 | 2 | PS51307 | |
| Domain | EGF-like_CS | 8.57e-04 | 261 | 213 | 10 | IPR013032 | |
| Domain | PP2C | 8.84e-04 | 17 | 213 | 3 | IPR015655 | |
| Domain | EGF_2 | 9.62e-04 | 265 | 213 | 10 | PS01186 | |
| Domain | PP2C | 1.24e-03 | 19 | 213 | 3 | PF00481 | |
| Domain | NIDO_dom | 1.27e-03 | 5 | 213 | 2 | IPR003886 | |
| Domain | FYrich_C | 1.27e-03 | 5 | 213 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.27e-03 | 5 | 213 | 2 | IPR003888 | |
| Domain | FYRC | 1.27e-03 | 5 | 213 | 2 | SM00542 | |
| Domain | FYRN | 1.27e-03 | 5 | 213 | 2 | SM00541 | |
| Domain | NIDO | 1.27e-03 | 5 | 213 | 2 | SM00539 | |
| Domain | NIDO | 1.27e-03 | 5 | 213 | 2 | PF06119 | |
| Domain | NIDO | 1.27e-03 | 5 | 213 | 2 | PS51220 | |
| Domain | YD | 1.27e-03 | 5 | 213 | 2 | IPR006530 | |
| Domain | FYRN | 1.27e-03 | 5 | 213 | 2 | PF05964 | |
| Domain | FYRC | 1.27e-03 | 5 | 213 | 2 | PF05965 | |
| Domain | FYRC | 1.27e-03 | 5 | 213 | 2 | PS51543 | |
| Domain | FYRN | 1.27e-03 | 5 | 213 | 2 | PS51542 | |
| Domain | IQ | 1.30e-03 | 71 | 213 | 5 | PF00612 | |
| Domain | PP2Cc | 1.44e-03 | 20 | 213 | 3 | SM00332 | |
| Domain | - | 1.44e-03 | 20 | 213 | 3 | 3.60.40.10 | |
| Domain | PPM-type_phosphatase_dom | 1.44e-03 | 20 | 213 | 3 | IPR001932 | |
| Domain | PPM_2 | 1.44e-03 | 20 | 213 | 3 | PS51746 | |
| Domain | EGF_3 | 1.55e-03 | 235 | 213 | 9 | PS50026 | |
| Domain | - | 1.57e-03 | 74 | 213 | 5 | 3.40.50.410 | |
| Domain | - | 1.84e-03 | 46 | 213 | 4 | 4.10.400.10 | |
| Domain | BRK | 1.88e-03 | 6 | 213 | 2 | SM00592 | |
| Domain | Na_trans_cytopl | 1.88e-03 | 6 | 213 | 2 | PF11933 | |
| Domain | BRK_domain | 1.88e-03 | 6 | 213 | 2 | IPR006576 | |
| Domain | Na_trans_cytopl | 1.88e-03 | 6 | 213 | 2 | IPR024583 | |
| Domain | BRK | 1.88e-03 | 6 | 213 | 2 | PF07533 | |
| Domain | EPHD | 1.92e-03 | 22 | 213 | 3 | PS51805 | |
| Domain | SEA | 1.92e-03 | 22 | 213 | 3 | PF01390 | |
| Domain | LDLRA_1 | 2.16e-03 | 48 | 213 | 4 | PS01209 | |
| Domain | SEA | 2.19e-03 | 23 | 213 | 3 | PS50024 | |
| Domain | SEA_dom | 2.19e-03 | 23 | 213 | 3 | IPR000082 | |
| Domain | LDrepeatLR_classA_rpt | 2.33e-03 | 49 | 213 | 4 | IPR002172 | |
| Domain | LDLa | 2.33e-03 | 49 | 213 | 4 | SM00192 | |
| Domain | LDLRA_2 | 2.33e-03 | 49 | 213 | 4 | PS50068 | |
| Domain | VWFA | 2.47e-03 | 82 | 213 | 5 | PS50234 | |
| Domain | KAZAL_2 | 2.51e-03 | 50 | 213 | 4 | PS51465 | |
| Domain | SRCR_2 | 2.62e-03 | 7 | 213 | 2 | PF15494 | |
| Domain | Kazal_dom | 2.70e-03 | 51 | 213 | 4 | IPR002350 | |
| Pubmed | BCORL1 C15orf39 BCOR AHNAK TNRC6A CHD6 ASCC3 FLNA ZCCHC8 MSANTD2 BEND3 SFMBT2 ZNF516 ZBTB10 PCCB | 9.49e-08 | 418 | 222 | 15 | 34709266 | |
| Pubmed | 1.90e-07 | 21 | 222 | 5 | 19592578 | ||
| Pubmed | BRPF3 BCOR STAB1 KMT2C MAST4 TNRC6A NAV2 BSN AKAP6 SHROOM3 INO80 PREPL SETBP1 ZNF516 HMGXB3 ESPL1 | 3.54e-07 | 529 | 222 | 16 | 14621295 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRNP1 C15orf39 ITGB5 REXO1 ST14 PCNX2 KMT2C CLCN7 AHNAK NAV2 SIPA1L2 FLNA SHROOM3 AOC2 INO80 NHSL1 GAS2L1 ZNF516 HMGXB3 ESPL1 PRDM16 AGRN RAB11FIP3 | 7.64e-07 | 1105 | 222 | 23 | 35748872 |
| Pubmed | ZNF518A STAB1 KMT2C NAV2 CHD6 AKAP6 TENM4 SETBP1 APPL1 PRDM16 | 2.08e-06 | 225 | 222 | 10 | 12168954 | |
| Pubmed | 6.79e-06 | 153 | 222 | 8 | 10718198 | ||
| Pubmed | 8.00e-06 | 43 | 222 | 5 | 33472061 | ||
| Pubmed | BRPF3 USP11 COQ8B BCOR ZNF518A MLKL TNRC6A IQSEC1 ASCC3 TAF6 SIPA1L2 GOPC ZCCHC8 BEND3 CHD9 RICTOR INO80 ZBTB10 TCF25 CSMD1 PRDM16 | 1.10e-05 | 1116 | 222 | 21 | 31753913 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDE4C GPATCH8 BCOR NSUN2 REXO1 WWC2 IQSEC1 KMT2A TAF6 FLNA ZCCHC8 RICTOR PRPF38B ZNF516 GZMB APPL1 ESPL1 | 1.13e-05 | 774 | 222 | 17 | 15302935 |
| Pubmed | BCL9L GALNT3 PABPC4 SNAP23 GPATCH8 BCOR KMT2C TNRC6A ASCC2 KMT2A CRYBG1 CHD6 ASCC3 TAF6 SHROOM3 ZCCHC8 PCDHB7 DGKZ RICTOR PRPF38B LAMP2 FAM98A INO80 KCTD3 AGRN | 1.21e-05 | 1497 | 222 | 25 | 31527615 | |
| Pubmed | GPATCH8 CSMD3 FNIP1 CHD6 SIPA1L2 FNIP2 UBR2 BEND3 TENM4 TENM3 TCF25 LARGE1 | 1.37e-05 | 407 | 222 | 12 | 12693553 | |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 1.47e-05 | 223 | 222 | 9 | 33187986 | |
| Pubmed | CHIT1 ITGB5 FNIP1 SIPA1L2 SHROOM3 TUT7 FIGNL2 PRPF38B EMILIN1 FAM222A TCF25 CTRL LARGE1 | 2.07e-05 | 496 | 222 | 13 | 31343991 | |
| Pubmed | 2.10e-05 | 9 | 222 | 3 | 15746173 | ||
| Pubmed | 2.10e-05 | 9 | 222 | 3 | 16382098 | ||
| Pubmed | SNAP23 GPATCH8 BCOR KMT2C WWC2 CRYBG1 PJA1 AKAP6 FLNA TUT7 DGKZ RICTOR INO80 UNC5C ZBTB10 TMPRSS2 HMGXB3 ESPL1 AGRN RAB11FIP3 | 2.38e-05 | 1084 | 222 | 20 | 11544199 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | PRSS2 CENPE USP11 BCORL1 C15orf39 BCOR TNRC6A BSN SIPA1L2 ZCCHC8 RNF8 PPM1G ZNF516 PPP6R2 | 2.87e-05 | 588 | 222 | 14 | 38580884 |
| Pubmed | The predictive value of maternal serum AFP to PAPP-A or b-hCG ratios in spontaneous preterm birth. | 4.06e-05 | 2 | 222 | 2 | 35620869 | |
| Pubmed | Prestin regulation and function in residual outer hair cells after noise-induced hearing loss. | 4.06e-05 | 2 | 222 | 2 | 24376553 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 28588744 | ||
| Pubmed | The interaction of DNA repair factors ASCC2 and ASCC3 is affected by somatic cancer mutations. | 4.06e-05 | 2 | 222 | 2 | 33139697 | |
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 4.06e-05 | 2 | 222 | 2 | 33526815 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 27690330 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 10391906 | ||
| Pubmed | Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia. | 4.06e-05 | 2 | 222 | 2 | 32776737 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 35499168 | ||
| Pubmed | Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma. | 4.06e-05 | 2 | 222 | 2 | 12538861 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 27121553 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 7507968 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 21988239 | ||
| Pubmed | BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer. | 4.06e-05 | 2 | 222 | 2 | 28073006 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 12661006 | ||
| Pubmed | Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. | 4.06e-05 | 2 | 222 | 2 | 2187193 | |
| Pubmed | ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3. | 4.06e-05 | 2 | 222 | 2 | 26863569 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 15567416 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 32459893 | ||
| Pubmed | BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders. | 4.06e-05 | 2 | 222 | 2 | 24047651 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 17449330 | ||
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 4.06e-05 | 2 | 222 | 2 | 24096970 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 12507753 | ||
| Pubmed | The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. | 4.06e-05 | 2 | 222 | 2 | 10500112 | |
| Pubmed | Cellular response to small molecules that selectively stall protein synthesis by the ribosome. | 4.06e-05 | 2 | 222 | 2 | 30875366 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 20946665 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 33283733 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 35484136 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 4.06e-05 | 2 | 222 | 2 | 24990319 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 10898108 | ||
| Pubmed | Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. | 4.06e-05 | 2 | 222 | 2 | 9521329 | |
| Pubmed | Lack of GOPC-ROS1 (FIG-ROS1) rearrangement in adult human gliomas. | 4.06e-05 | 2 | 222 | 2 | 24999209 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 31138428 | ||
| Pubmed | Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis. | 4.06e-05 | 2 | 222 | 2 | 19250736 | |
| Pubmed | ADAM10 is essential for cranial neural crest-derived maxillofacial bone development. | 4.06e-05 | 2 | 222 | 2 | 27221046 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 4.06e-05 | 2 | 222 | 2 | 23965409 | |
| Pubmed | Gene mutation profile in patients with acquired pure red cell aplasia. | 4.06e-05 | 2 | 222 | 2 | 32594217 | |
| Pubmed | Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR. | 4.06e-05 | 2 | 222 | 2 | 25231053 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 31626289 | ||
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 4.06e-05 | 2 | 222 | 2 | 36449053 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 24830635 | ||
| Pubmed | Characterization of a tryptase mRNA expressed in the human basophil cell line KU812. | 4.06e-05 | 2 | 222 | 2 | 8434231 | |
| Pubmed | Cloning and characterization of a second complementary DNA for human tryptase. | 4.06e-05 | 2 | 222 | 2 | 2203827 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 23224034 | ||
| Pubmed | BCOR and BCORL1 mutations in pediatric acute myeloid leukemia. | 4.06e-05 | 2 | 222 | 2 | 25596268 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 19617579 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 12696071 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 35015684 | ||
| Pubmed | The human mast cell tryptase tetramer: a fascinating riddle solved by structure. | 4.06e-05 | 2 | 222 | 2 | 10708850 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 32292079 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 31337736 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PABPC4 C15orf39 UPF3A WWC2 DENND1B IQSEC1 CRYBG1 PJA1 GNB2 ZCCHC8 DGKZ RICTOR CBL SHROOM1 ZC2HC1A KCTD3 TCF25 ESPL1 PPP6R2 | 4.26e-05 | 1038 | 222 | 19 | 26673895 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | WWC2 DENND1B MAST4 AHNAK IQSEC1 NAV2 KMT2A FNIP1 NR3C2 SIPA1L2 SHROOM3 ZCCHC8 RICTOR FAM98A CBL PPM1A NHSL1 | 4.33e-05 | 861 | 222 | 17 | 36931259 |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 4.83e-05 | 101 | 222 | 6 | 20551380 | |
| Pubmed | BCL9L USP11 PABPC4 BCORL1 C15orf39 GPATCH8 BCOR NSUN2 KMT2C GLI2 TNRC6A KMT2A CHD6 TAF6 MSANTD2 BEND3 INO80 PPM1G TIMM13 ZNF516 ZBTB10 PCCB PRDM16 | 4.85e-05 | 1429 | 222 | 23 | 35140242 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.03e-05 | 202 | 222 | 8 | 33005030 | |
| Pubmed | Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein. | 5.05e-05 | 32 | 222 | 4 | 28656962 | |
| Pubmed | 5.40e-05 | 103 | 222 | 6 | 10819331 | ||
| Pubmed | Amelogenesis imperfecta in a new animal model--a mutation in chromosome 5 (human 4q21). | 5.41e-05 | 12 | 222 | 3 | 15271968 | |
| Pubmed | 5.41e-05 | 12 | 222 | 3 | 9096102 | ||
| Pubmed | ZNF174 HESX1 KMT2C GLI2 KMT2A NR3C2 PJA1 TCF21 TUT7 CBL TIMM13 KLF7 PLXNC1 HMGXB3 PRDM16 | 5.72e-05 | 709 | 222 | 15 | 22988430 | |
| Pubmed | 8.87e-05 | 14 | 222 | 3 | 19850283 | ||
| Pubmed | ZNF174 PABPC4 ZNF184 BCORL1 C15orf39 BCOR NSUN2 MLKL KMT2C KMT2A TAF6 FLNA GOPC MSANTD2 BEND3 CHD9 PRPF38B PPM1G ZNF516 | 9.47e-05 | 1103 | 222 | 19 | 34189442 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L BCORL1 C15orf39 BCOR KMT2C KMT2A GNB2 INO80 ZNF516 PRDM16 | 9.53e-05 | 351 | 222 | 10 | 38297188 |
| Pubmed | ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2. | 1.01e-04 | 38 | 222 | 4 | 30629181 | |
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 27636103 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 11728464 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 21646476 | ||
| Pubmed | TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. | 1.21e-04 | 3 | 222 | 2 | 22521249 | |
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 23932714 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 25301452 | ||
| Pubmed | Blocking estrogen-induced AMH expression is crucial for normal follicle formation. | 1.21e-04 | 3 | 222 | 2 | 33658225 | |
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 20626753 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 20142329 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 12610651 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 18062964 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 22493320 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 18784617 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 24226839 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 7532600 | ||
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 24909170 | ||
| Pubmed | Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer. | 1.21e-04 | 3 | 222 | 2 | 22977732 | |
| Pubmed | 1.21e-04 | 3 | 222 | 2 | 18485666 | ||
| GeneFamily | Proteases, serine | 1.01e-06 | 63 | 153 | 7 | 738 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.81e-05 | 9 | 153 | 3 | 1203 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.19e-04 | 57 | 153 | 5 | 1179 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 3.70e-04 | 17 | 153 | 3 | 701 | |
| GeneFamily | Collagens|Collagen proteoglycans | 7.00e-04 | 5 | 153 | 2 | 575 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.19e-03 | 25 | 153 | 3 | 504 | |
| Coexpression | NABA_MATRISOME | HGFAC PRSS2 TMPRSS15 ADAM10 ST14 BGLAP FCN1 RPTN C1QTNF7 ITIH6 INTS6L AMH COL9A1 COL12A1 CDCP2 TECTA EMILIN1 SNED1 PLXNC1 TNFSF8 PAPPA HABP2 LTBP1 CTSG CTSH AGRN IL4 | 1.47e-07 | 1026 | 219 | 27 | M5889 |
| Coexpression | NABA_MATRISOME | HGFAC PRSS2 TMPRSS15 ADAM10 ST14 BGLAP FCN1 RPTN C1QTNF7 INTS6L AMH COL9A1 COL12A1 CDCP2 TECTA EMILIN1 SNED1 PLXNC1 TNFSF8 PAPPA HABP2 LTBP1 CTSG CTSH AGRN IL4 | 3.74e-07 | 1008 | 219 | 26 | MM17056 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZBTB38 SNAP23 ITGB5 ZNF518A KMT2C WWC2 MAST4 CLIC5 AHNAK IQSEC1 AK1 C1QTNF7 SHROOM3 COL12A1 TCF21 GOPC TUT7 RICTOR CBL ELL2 TCF25 | 1.09e-05 | 854 | 219 | 21 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZBTB38 SNAP23 ITGB5 ZNF518A KMT2C WWC2 MAST4 CLIC5 AHNAK IQSEC1 AK1 C1QTNF7 SHROOM3 COL12A1 TCF21 GOPC TUT7 RICTOR CBL ELL2 TCF25 | 1.95e-05 | 888 | 219 | 21 | MM1018 |
| Coexpression | AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1 | 3.49e-05 | 191 | 219 | 9 | M39108 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 3.63e-05 | 192 | 219 | 9 | M8272 | |
| Coexpression | GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN | 4.62e-05 | 198 | 219 | 9 | M6280 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP | 4.80e-05 | 199 | 219 | 9 | M9366 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP | 4.99e-05 | 200 | 219 | 9 | M7889 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP | 4.99e-05 | 200 | 219 | 9 | M5677 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | GLI2 C1R KAZN CACNA2D1 COL12A1 EMILIN1 SNED1 TENM4 TENM3 SETBP1 UNC5C PAPPA LTBP1 | 2.21e-11 | 197 | 221 | 13 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | HOXB3 LRRTM4 KAZN C1QTNF7 CACNA2D1 COL12A1 SNED1 TENM4 SETBP1 UNC5C PAPPA LTBP1 | 2.64e-10 | 193 | 221 | 12 | e6b75be08e33c1de079fb5c02f0b4468128b369c |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | GLI2 NAV2 C1R KAZN CACNA2D1 GRIK4 EMILIN1 SNED1 TENM3 SETBP1 UNC5C PAPPA | 3.54e-10 | 198 | 221 | 12 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | GLI2 C1R KAZN CACNA2D1 EMILIN1 SNED1 TENM3 SETBP1 UNC5C PAPPA LTBP1 | 4.60e-09 | 197 | 221 | 11 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | HOXB3 GLI2 KAZN CACNA2D1 TCF21 EMILIN1 SNED1 TENM3 SETBP1 UNC5C LTBP1 | 5.11e-09 | 199 | 221 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | GLI2 LRRTM4 C1R COL12A1 TCF21 GRIK4 EMILIN1 TENM3 UNC5C LTBP1 | 4.10e-08 | 190 | 221 | 10 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | GLI2 LRRTM4 C1R COL12A1 TCF21 GRIK4 EMILIN1 TENM3 UNC5C LTBP1 | 4.10e-08 | 190 | 221 | 10 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | HOXB3 MYO3B SCN3A CRYBG1 NR3C2 KAZN SHROOM3 TENM3 PAPPA PRDM16 | 4.31e-08 | 191 | 221 | 10 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | WWC2 MAST4 CLIC5 NAV2 NR3C2 SHROOM3 NHSL1 TMPRSS2 ROS1 PRDM16 | 4.31e-08 | 191 | 221 | 10 | ca5669bd6f4a17471acae3eb229f845cc2e08efa |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | ERBB3 WWC2 MAST4 CLIC5 NAV2 NR3C2 SHROOM3 TMPRSS2 PRDM16 LARGE1 | 4.31e-08 | 191 | 221 | 10 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | HOXB3 GLI2 KAZN CACNA2D1 TCF21 GRIK4 EMILIN1 SNED1 SETBP1 UNC5C | 4.75e-08 | 193 | 221 | 10 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | HOXB3 GLI2 KAZN CACNA2D1 TCF21 EMILIN1 SNED1 TENM3 SETBP1 UNC5C | 6.05e-08 | 198 | 221 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.65e-08 | 200 | 221 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-07 | 180 | 221 | 9 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-07 | 180 | 221 | 9 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.02e-07 | 186 | 221 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.40e-07 | 188 | 221 | 9 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.60e-07 | 189 | 221 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-07 | 191 | 221 | 9 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 5.03e-07 | 191 | 221 | 9 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.49e-07 | 193 | 221 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-07 | 194 | 221 | 9 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.73e-07 | 194 | 221 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.73e-07 | 194 | 221 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-07 | 194 | 221 | 9 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.73e-07 | 194 | 221 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.73e-07 | 194 | 221 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-07 | 195 | 221 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-07 | 195 | 221 | 9 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 5.98e-07 | 195 | 221 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-07 | 195 | 221 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-07 | 196 | 221 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-07 | 196 | 221 | 9 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-07 | 196 | 221 | 9 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.51e-07 | 197 | 221 | 9 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-07 | 197 | 221 | 9 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.51e-07 | 197 | 221 | 9 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-07 | 197 | 221 | 9 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-07 | 197 | 221 | 9 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.79e-07 | 198 | 221 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.09e-07 | 199 | 221 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-07 | 199 | 221 | 9 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-07 | 200 | 221 | 9 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-07 | 200 | 221 | 9 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-07 | 200 | 221 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.54e-07 | 152 | 221 | 8 | 0fda8980b10ce16179dea92301db74d728f41794 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.11e-06 | 178 | 221 | 8 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-06 | 181 | 221 | 8 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-06 | 183 | 221 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-06 | 183 | 221 | 8 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 221 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 221 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 221 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.31e-06 | 186 | 221 | 8 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-06 | 186 | 221 | 8 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.48e-06 | 187 | 221 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 4.48e-06 | 187 | 221 | 8 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-06 | 187 | 221 | 8 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.48e-06 | 187 | 221 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.66e-06 | 188 | 221 | 8 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.66e-06 | 188 | 221 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-06 | 189 | 221 | 8 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.04e-06 | 190 | 221 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.04e-06 | 190 | 221 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 190 | 221 | 8 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.23e-06 | 191 | 221 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.23e-06 | 191 | 221 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-06 | 191 | 221 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 191 | 221 | 8 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 5.44e-06 | 192 | 221 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 192 | 221 | 8 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.44e-06 | 192 | 221 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 192 | 221 | 8 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.44e-06 | 192 | 221 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 192 | 221 | 8 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 5.44e-06 | 192 | 221 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.44e-06 | 192 | 221 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 5.44e-06 | 192 | 221 | 8 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 5.44e-06 | 192 | 221 | 8 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.65e-06 | 193 | 221 | 8 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.65e-06 | 193 | 221 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.65e-06 | 193 | 221 | 8 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.65e-06 | 193 | 221 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.65e-06 | 193 | 221 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.65e-06 | 193 | 221 | 8 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.65e-06 | 193 | 221 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-06 | 193 | 221 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.65e-06 | 193 | 221 | 8 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 194 | 221 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-06 | 194 | 221 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-06 | 194 | 221 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.87e-06 | 194 | 221 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 194 | 221 | 8 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 194 | 221 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 195 | 221 | 8 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.09e-06 | 195 | 221 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 195 | 221 | 8 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.33e-06 | 196 | 221 | 8 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-06 | 196 | 221 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.57e-06 | 197 | 221 | 8 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| Computational | Serine proteases. | 6.85e-06 | 39 | 131 | 6 | MODULE_109 | |
| Drug | diisopropylfluorophosphate | TPSAB1 HGFAC PRSS2 KLK7 TMPRSS15 ST14 TMPRSS9 PLA2G3 KLK14 PREPL GZMB TMPRSS2 HABP2 CTRL CTSG TPSB2 | 9.14e-08 | 321 | 218 | 16 | CID000005936 |
| Drug | CHCl | 1.96e-07 | 65 | 218 | 8 | CID006432229 | |
| Drug | AC1Q6PMP | TPSAB1 PRSS2 KLK7 TMPRSS15 ST14 CASP2 GZMB CTRL CTSG CTSH TPSB2 | 7.41e-07 | 169 | 218 | 11 | CID000103535 |
| Drug | AC1NUP69 | 1.64e-06 | 10 | 218 | 4 | CID005487154 | |
| Drug | isocoumarin | 1.80e-06 | 39 | 218 | 6 | CID000068108 | |
| Drug | NSC89634 | 1.80e-06 | 39 | 218 | 6 | CID000070877 | |
| Drug | DB04623 | 1.80e-06 | 39 | 218 | 6 | CID005459358 | |
| Drug | NSC-648146 | 3.81e-06 | 12 | 218 | 4 | CID000372649 | |
| Drug | Z-Lys-OH | 6.31e-06 | 28 | 218 | 5 | CID000075172 | |
| Drug | AC1NRA23 | 6.39e-06 | 73 | 218 | 7 | CID005287657 | |
| Drug | benzamidine | 1.26e-05 | 147 | 218 | 9 | CID000002332 | |
| Drug | Leupeptin hydrochloride | TPSAB1 PRSS2 KLK7 ST14 STAB1 CASP2 KLK14 TMPRSS2 CTRL CTSG CTSH TPSB2 | 1.53e-05 | 276 | 218 | 12 | CID000003910 |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.23e-05 | 198 | 218 | 10 | 3396_UP | |
| Drug | TLCK | 2.24e-05 | 158 | 218 | 9 | CID000004427 | |
| Drug | enzacamene | 3.51e-05 | 129 | 218 | 8 | ctd:C038939 | |
| Drug | A80a | 3.51e-05 | 20 | 218 | 4 | CID005487000 | |
| Disease | Intellectual Disability | NSUN2 KMT2C ADRA2B SCN1A SCN3A IQSEC1 PJA1 ASCC3 TAF6 AKAP6 ZCCHC8 CASP2 PREPL KLF7 SETBP1 LARGE1 | 2.25e-07 | 447 | 216 | 16 | C3714756 |
| Disease | Carcinoma, Transitional Cell | 1.21e-05 | 41 | 216 | 5 | C0007138 | |
| Disease | serum gamma-glutamyl transferase measurement | HGFAC PDE4C GALNT3 CSMD3 STAB1 WWC2 AHNAK HACE1 NAV2 KMT2A SIPA1L2 AMH CHD9 PPM1G ADORA2A-AS1 TENM4 SLCO1A2 TMPRSS2 CSMD1 PPP6R2 | 1.44e-05 | 914 | 216 | 20 | EFO_0004532 |
| Disease | tryptase beta-2 measurement | 3.15e-05 | 9 | 216 | 3 | EFO_0008306 | |
| Disease | Leukemia, Myelocytic, Acute | 4.35e-05 | 173 | 216 | 8 | C0023467 | |
| Disease | glucagon-like peptide-1 measurement | 4.47e-05 | 10 | 216 | 3 | EFO_0008465 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.47e-05 | 10 | 216 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.47e-05 | 10 | 216 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | urate measurement, spine bone mineral density | 6.71e-05 | 58 | 216 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.11e-05 | 12 | 216 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | HGFAC BRPF3 UPF3A GPATCH8 ITGB5 HOXB3 ADRA2B DENND1B TNRC6A ASCC2 C1QTNF7 GNB2 AMH SHROOM3 GOPC INO80 TENM4 PLXNC1 ZNF516 PITPNM3 LTBP1 CMTR2 CTSH PRDM16 | 9.30e-05 | 1392 | 216 | 24 | EFO_0005763 |
| Disease | coronary aneurysm | 1.22e-04 | 35 | 216 | 4 | EFO_1000881 | |
| Disease | Epilepsies, Partial | 1.59e-04 | 3 | 216 | 2 | C0014547 | |
| Disease | conotruncal heart malformations | 1.98e-04 | 114 | 216 | 6 | MONDO_0016581 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 2.02e-04 | 16 | 216 | 3 | C0751885 | |
| Disease | epilepsy (implicated_via_orthology) | 2.07e-04 | 163 | 216 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | cortical thickness | ERBB3 ADAM10 ITGB5 STAB1 DENND1B MAST4 TNRC6A NAV2 KMT2A FGFR3 AKAP6 FNIP2 SHROOM3 COL12A1 BEND3 NHSL1 PLXNC1 SLCO1A2 KCTD3 PCCB | 2.14e-04 | 1113 | 216 | 20 | EFO_0004840 |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.44e-04 | 17 | 216 | 3 | C0751883 | |
| Disease | hepatitis (biomarker_via_orthology) | 3.17e-04 | 4 | 216 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | tongue cancer (is_marker_for) | 3.17e-04 | 4 | 216 | 2 | DOID:8649 (is_marker_for) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.29e-04 | 45 | 216 | 4 | EFO_0004623, EFO_0004791 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 3.44e-04 | 19 | 216 | 3 | C0751884 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 3.58e-04 | 46 | 216 | 4 | EFO_0008003, GO_0097332 | |
| Disease | Myelomonocytic leukemia | 5.26e-04 | 5 | 216 | 2 | C0027019 | |
| Disease | Profound Mental Retardation | 5.74e-04 | 139 | 216 | 6 | C0020796 | |
| Disease | Mental deficiency | 5.74e-04 | 139 | 216 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 5.74e-04 | 139 | 216 | 6 | C0025363 | |
| Disease | Bladder Neoplasm | 5.96e-04 | 140 | 216 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.19e-04 | 141 | 216 | 6 | C0005684 | |
| Disease | Myasthenic Syndromes, Congenital | 6.99e-04 | 24 | 216 | 3 | C0751882 | |
| Disease | colorectal health | 7.30e-04 | 201 | 216 | 7 | EFO_0008460 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 7.85e-04 | 6 | 216 | 2 | EFO_0802705 | |
| Disease | Pituitary Hormone Deficiency, Combined, 1 | 7.85e-04 | 6 | 216 | 2 | C2751608 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 7.85e-04 | 6 | 216 | 2 | EFO_0801767 | |
| Disease | Adenoid Cystic Carcinoma | 8.60e-04 | 100 | 216 | 5 | C0010606 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.09e-03 | 7 | 216 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 1.11e-03 | 28 | 216 | 3 | DOID:12236 (biomarker_via_orthology) | |
| Disease | testosterone measurement | HGFAC SPEM3 CENPE PABPC4 BCORL1 SNAP23 CSMD3 REXO1 DENND1B KAZN PLSCR3 CACNA2D1 SHROOM3 UGT1A5 TUT7 BCAS1 UGT1A4 SLCO1A2 ZBTB10 PCCB | 1.17e-03 | 1275 | 216 | 20 | EFO_0004908 |
| Disease | fibrinogen measurement | 1.27e-03 | 109 | 216 | 5 | EFO_0004623 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.29e-03 | 286 | 216 | 8 | EFO_0004346, EFO_0006930 | |
| Disease | Liver carcinoma | HGFAC CENPE HMGCR KMT2C ADRA2B AFP KMT2A EPS8L3 ADGRG7 PITPNM3 CSMD1 | 1.37e-03 | 507 | 216 | 11 | C2239176 |
| Disease | Succinimide measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0022118 | |
| Disease | Idiopathic Myoclonic Epilepsy | 1.45e-03 | 8 | 216 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.45e-03 | 8 | 216 | 2 | C0338479 | |
| Disease | cholelithiasis, bilirubin measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-24849 measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0800909 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 1.45e-03 | 8 | 216 | 2 | C0751120 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0802740 | |
| Disease | Myoclonic Encephalopathy | 1.45e-03 | 8 | 216 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 1.45e-03 | 8 | 216 | 2 | C0393703 | |
| Disease | X-16946 measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0800766 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0021260 | |
| Disease | X-11530 measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0021249 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 1.45e-03 | 8 | 216 | 2 | C0393695 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0801034 | |
| Disease | X-11522 measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.45e-03 | 8 | 216 | 2 | EFO_0800692 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.49e-03 | 67 | 216 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.66e-03 | 69 | 216 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | word list delayed recall measurement, memory performance | 1.79e-03 | 33 | 216 | 3 | EFO_0004874, EFO_0006805 | |
| Disease | X-11442 measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0802127 | |
| Disease | Myoclonic Epilepsy | 1.86e-03 | 9 | 216 | 2 | C0014550 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.86e-03 | 9 | 216 | 2 | EFO_0004570, GO_0009410 | |
| Disease | cardiovascular disease | HGFAC HMGCR UPF3A CHKB REXO1 HOXB3 SIPA1L2 UNC5C PCCB PRDM16 | 2.10e-03 | 457 | 216 | 10 | EFO_0000319 |
| Disease | age at first sexual intercourse measurement | 2.16e-03 | 383 | 216 | 9 | EFO_0009749 | |
| Disease | X-21448 measurement | 2.31e-03 | 10 | 216 | 2 | EFO_0800816 | |
| Disease | Epilepsy, Myoclonic, Infantile | 2.31e-03 | 10 | 216 | 2 | C0917800 | |
| Disease | X-23974 measurement | 2.31e-03 | 10 | 216 | 2 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 2.31e-03 | 10 | 216 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.31e-03 | 10 | 216 | 2 | EFO_0802185 | |
| Disease | Acute Myeloid Leukemia, M1 | 2.31e-03 | 125 | 216 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 2.31e-03 | 125 | 216 | 5 | C1879321 | |
| Disease | brain measurement, neuroimaging measurement | ERBB3 GPATCH8 DENND1B MAST4 TNRC6A NAV2 FGFR3 BEND3 NHSL1 PAPPA PRDM16 | 2.57e-03 | 550 | 216 | 11 | EFO_0004346, EFO_0004464 |
| Disease | granulosa cell tumor (is_marker_for) | 2.81e-03 | 11 | 216 | 2 | DOID:2999 (is_marker_for) | |
| Disease | histidine betaine (hercynine) measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | Myoclonic Astatic Epilepsy | 2.81e-03 | 11 | 216 | 2 | C0393702 | |
| Disease | pregnenetriol sulfate measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0600039 | |
| Disease | aldosterone measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0010219 | |
| Disease | lactate measurement | 2.91e-03 | 39 | 216 | 3 | EFO_0007745 | |
| Disease | coronary artery disease | HGFAC HMGCR CHKB ITGB5 DENND1B MAST4 CLIC5 C1R BSN SHROOM3 TCF21 GRIK4 INO80 PPM1A ENAM UNC5C PCCB PRDM16 | 3.14e-03 | 1194 | 216 | 18 | EFO_0001645 |
| Disease | asthma, response to diisocyanate | 3.23e-03 | 261 | 216 | 7 | EFO_0006995, MONDO_0004979 | |
| Disease | p-cresol glucuronide measurement | 3.35e-03 | 12 | 216 | 2 | EFO_0800079 | |
| Disease | dementia (is_implicated_in) | 3.35e-03 | 12 | 216 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | craniosynostosis (is_implicated_in) | 3.35e-03 | 12 | 216 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | biliverdin measurement | 3.35e-03 | 12 | 216 | 2 | EFO_0021033 | |
| Disease | mean platelet volume | ZBTB38 BCORL1 BCOR MAST4 TNRC6A NR3C2 GNB2 PCDHGA4 CHD9 BCAS1 SETBP1 ZBTB10 LTBP1 ESPL1 PRDM16 RAB11FIP3 | 3.61e-03 | 1020 | 216 | 16 | EFO_0004584 |
| Disease | Infantile Severe Myoclonic Epilepsy | 3.95e-03 | 13 | 216 | 2 | C0751122 | |
| Disease | pregnenetriol disulfate measurement | 3.95e-03 | 13 | 216 | 2 | EFO_0800587 | |
| Disease | bronchiolitis obliterans (is_marker_for) | 3.95e-03 | 13 | 216 | 2 | DOID:2799 (is_marker_for) | |
| Disease | retinol dehydrogenase 16 measurement | 3.95e-03 | 13 | 216 | 2 | EFO_0802007 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KAAGPGGTGQAECQV | 81 | Q6ZR03 | |
| QGDSGGPLVCQKGNT | 211 | P40313 | |
| PDCRKGTELGQGATQ | 251 | Q5U5X8 | |
| EVGNSQAVCPGTLNG | 21 | P21860 | |
| SNVGKDNPQGSFDCI | 86 | O00472 | |
| AAKGQNCGGLVQGPN | 26 | Q96PZ7 | |
| AVQCGNPGTTANGKV | 3111 | Q7Z407 | |
| GTECTPGESKNLGQK | 396 | O14672 | |
| EGVKCGGVLSAPSGN | 26 | Q5VXM1 | |
| HCGLQGDGANTTPQK | 211 | Q9H1I8 | |
| GDSGGPLVCNKVAQG | 201 | P10144 | |
| AGGGRREQSQKPCSN | 91 | P86434 | |
| GFGDPLICDNQVSTG | 96 | O00468 | |
| CGKKGSQAGAEGQPS | 766 | Q5H9F3 | |
| LVTADGSFDCQGNPG | 231 | Q8IYT2 | |
| LCPNKGGAFKQTSDG | 271 | Q9ULD4 | |
| GIKSSGCDVNLPGVN | 5496 | Q09666 | |
| ALPNSGQGQKEGVCG | 276 | P18089 | |
| GQGQKEGVCGASPED | 281 | P18089 | |
| KAANVLGGACGLQPG | 101 | Q6NUN0 | |
| LQPAPQDSGKSCGVD | 136 | P10523 | |
| SLQTCGKDTPNAGNP | 101 | Q96K78 | |
| SGAVGGCLAKDGLQQ | 11 | Q9Y259 | |
| AGGKKQAQPSCAPAS | 1301 | Q6W2J9 | |
| GHPSLKQDACQGDSG | 641 | P00736 | |
| AGIDGESIGNCPFSQ | 181 | Q9NZA1 | |
| NGKAESLPGQPLACN | 706 | Q9P241 | |
| ADNQPTGKISPCAGE | 406 | Q5JR59 | |
| GINGFLSQNCIVDPG | 506 | Q6P1R3 | |
| SGPDCGLGNDNAVKQ | 576 | P24386 | |
| QGITAIRNGDPDGQC | 261 | O75154 | |
| QKPGSNAFVGGAKNC | 731 | Q5JSJ4 | |
| GGNPGASCKDTSGEI | 401 | Q9HD26 | |
| GGSLAAKQCLLNGAP | 1041 | Q9ULG1 | |
| LENNGSKKDGVCGPP | 491 | Q08J23 | |
| LNEPQKRDCGSTGAG | 171 | Q5T5X7 | |
| FEKGQDAGLCSINPV | 721 | O75106 | |
| GPSPGQDTFCQGKAD | 411 | Q13231 | |
| STFGNGDCPGNGEKL | 591 | P35228 | |
| DSGGNGLVTCSIPDN | 406 | Q9Y5G9 | |
| AQQGLTDSCQSGGVP | 486 | Q13310 | |
| AGIVAGNSSECGQQP | 116 | O95461 | |
| SLCNGDSPGPVQKNL | 346 | Q674X7 | |
| FGCGNQLPKTDGGSE | 3831 | Q8NEZ4 | |
| DGNCEGSGFPVGIKQ | 481 | P08235 | |
| SGNDIQGIEPGTFKC | 261 | Q86VH4 | |
| AGVPQGGKDSCQGDS | 206 | Q9P0G3 | |
| GNLLATPGQLQCLAG | 106 | Q9BV99 | |
| GPGSGKGTQCEKIVQ | 16 | P00568 | |
| LGVQGACKDNPGENA | 821 | P04035 | |
| GNFSLCVENKNGSGP | 121 | Q9H9K5 | |
| CVENKNGSGPFLGNI | 126 | Q9H9K5 | |
| NDGSQLGALVSPECG | 201 | Q6DN90 | |
| VCEDQPGQAKAFGQG | 461 | Q9UKG1 | |
| CQLLGLGSGNSSKPI | 716 | P98073 | |
| PNGGADQKCLKVNSP | 786 | Q8NCM2 | |
| FGQGGGSPVCLAQVK | 1761 | Q9UPA5 | |
| AAGSGIPQIKCFLNG | 201 | P51798 | |
| DAICGSPAAGLNVGN | 146 | Q8N1V2 | |
| LFKGGQNSLAGPQEC | 756 | Q12766 | |
| GESCLSQQDGAAGVP | 1311 | Q5SYE7 | |
| DAPASGSACSGLNKQ | 631 | Q9UKJ3 | |
| GSACSGLNKQEPGGS | 636 | Q9UKJ3 | |
| QPRKGGAQHGVSSCE | 1911 | A6NKB5 | |
| GAGQPLGQAAEESNC | 111 | Q9NRY6 | |
| QEQCPVAVEKTSGGG | 631 | O60486 | |
| QETIGSQCGKALPGL | 561 | Q14766 | |
| QCLGAAKQGPVGNPS | 176 | Q08493 | |
| GANTPDATKGCPDVQ | 186 | Q96PD5 | |
| NPLGSRCQGASGNKL | 61 | Q9NTX9 | |
| TCKQGSQRVQGPEDA | 36 | Q8TE67 | |
| NKCLVAQGRPSQKGG | 491 | Q8NCW6 | |
| CGEKGQDGAGKSNPT | 406 | Q8N819 | |
| DKNGVTPLDLCVQGG | 226 | Q8IYU2 | |
| CNKDLGGGFEDSPAQ | 291 | Q6UY01 | |
| QEGAQLGENKPSTCS | 6 | Q9UBX0 | |
| AGIPDSKKNACNGDS | 191 | P49862 | |
| SKKNACNGDSGGPLV | 196 | P49862 | |
| PSKNAAKTGAGEVNG | 266 | O60662 | |
| GSICGDDQNGPKIAV | 76 | P13473 | |
| GQECIFSKVSGGPQG | 91 | Q96KN4 | |
| APSGNFVACGGLDNI | 106 | P62879 | |
| QCSGGSGLLNLTPAQ | 871 | P10070 | |
| GCQLGFGAPSSLNKN | 1126 | P10070 | |
| SDQGGLGAEACPENK | 201 | O75840 | |
| QEPLCLVALGGDSNG | 51 | P03971 | |
| APGQSLTLQCGSDVG | 236 | Q6PI73 | |
| APGQSLTLQCGSDVG | 236 | O75022 | |
| GEQVGGIFSPLTQKC | 221 | Q13219 | |
| NAKTVCEGDSGGPLV | 236 | A1L453 | |
| GDSGGPLACEKNGVA | 596 | Q04756 | |
| VKNGCGGEIESPASS | 71 | P18084 | |
| ATGDIPFQGCNSEKI | 406 | Q8NB16 | |
| AGIINLCKPGNSGIQ | 296 | Q6R327 | |
| CIAGQAGAKPSGAES | 16 | P02818 | |
| GNQPKVASGCLDINS | 356 | P05166 | |
| EKGDAGQSQSCATGP | 101 | O00602 | |
| GNNGKTVCSIQDDVP | 376 | Q9Y5E2 | |
| NLQKPGQDTCQGDSG | 496 | Q14520 | |
| PQATGDQKSGGKCET | 2086 | Q3L8U1 | |
| NNTSQKGLEGRGLPC | 1331 | Q14674 | |
| GLAGLNSCPVKEANQ | 116 | P05112 | |
| CNSVKGPGDLEAPSN | 1376 | Q99715 | |
| QSVCEPGAAPKQGAG | 901 | P54289 | |
| TISISKDGNCQSGGP | 1736 | Q8TD26 | |
| KDGNCQSGGPEAEIA | 1741 | Q8TD26 | |
| EAALCAQGPKQASGA | 66 | Q96MA1 | |
| GCPVEALVKDNGNGT | 716 | P21333 | |
| KCGQPGDSGRTANGL | 576 | Q99501 | |
| LCLDVGENNQGGKPL | 516 | Q14435 | |
| NGLLGNIGLSQFCSP | 201 | Q8TF40 | |
| AGANIPCGDDNKKAN | 866 | Q9P278 | |
| KLKNNSPGTAEGCGG | 141 | P14651 | |
| NVNQGPTCNVGSKGV | 61 | Q86UU0 | |
| PAQNSCGITLEKAGG | 86 | Q6ZTY9 | |
| LAGGVPLDQCQGLSQ | 326 | Q96D53 | |
| GNFVSPVKNQGACGS | 126 | P09668 | |
| GNIQSLDTPGASCGI | 26 | Q8N1E2 | |
| NVEEGSPACQAGLKA | 1176 | O15021 | |
| EGATNNSQKAFGCPG | 536 | Q6UXX5 | |
| VEQSSQKECGQPAGQ | 3596 | Q03164 | |
| AFKGDSGGPLLCNNV | 196 | P08311 | |
| GLAGGCQAPQALKAQ | 41 | Q96LR7 | |
| KAGSCQQGSGPAASA | 836 | P22681 | |
| NSNGGNELCPKIRIG | 36 | P20849 | |
| KNTPCLKNDLGGDGN | 981 | Q9NRM1 | |
| EEGQAQAGQCPSLEG | 711 | Q9Y6C2 | |
| LCQQAAAGAGLPGLQ | 601 | A6NMB9 | |
| EGAPPCGLNKEQSNL | 881 | Q9Y4K1 | |
| QEPDGAGAKSPTCQK | 696 | Q13574 | |
| KNIINLLGACTQGGP | 536 | P22607 | |
| TLSNGKLCGAGEPDQ | 886 | Q16099 | |
| QETQGAGKNSKGCNP | 331 | O75363 | |
| PSENNLAFLCGGSGD | 611 | Q6P3S1 | |
| NSSIPGAATEGCKDG | 96 | A6NK97 | |
| GPIQAEVKGATGECN | 691 | Q9Y597 | |
| QQDGKNHAGSPGCEE | 331 | P42575 | |
| AICASGQPRGNQLKG | 11 | Q9BXJ2 | |
| KPLTCGGGSGIVQNT | 2526 | Q02224 | |
| QDQGAACSGLPPGKE | 851 | Q96JN8 | |
| VCLSLGGSGNTEPQK | 91 | Q8NAC3 | |
| ASESCSKNGPERGGQ | 661 | O75170 | |
| KPTGDEQSSGCLENQ | 76 | P02771 | |
| VQPGGSLKLSCAASG | 31 | A0A0B4J1V6 | |
| SPLSGSALCGGKQEA | 636 | P49848 | |
| QDKQGCLGSGDGVPN | 46 | Q3SY00 | |
| CLGSGDGVPNQDLQQ | 51 | Q3SY00 | |
| QVQSSQDGGCPKEGK | 361 | Q8N1G1 | |
| LIGKANGNVGTGTCD | 731 | O14607 | |
| QGDSGGPLVCKVNGT | 221 | Q15661 | |
| QGDSGGPLVCKVNGT | 221 | P20231 | |
| QGCQGDGDAGVKASP | 731 | Q13671 | |
| CNGSLDTSQGEKGAP | 506 | P35499 | |
| NLENPGTSVKGDCGN | 1556 | P35499 | |
| GTSVKGDCGNPSIGI | 1561 | P35499 | |
| CESGQPVKSQGKGEV | 181 | O76064 | |
| GENSKQLPGPQKCSD | 386 | Q5VVP1 | |
| LVQEGTGGKTQLAGC | 401 | P58743 | |
| CVNAPPKKAQEGGGS | 126 | Q8NCA5 | |
| GNKGSCVLSSPGEDA | 21 | Q8N2H9 | |
| DTGGGKQESCAPGAV | 306 | Q9H1J1 | |
| VDGSAQCPGLASEKQ | 1101 | Q9HAZ2 | |
| SQPNTVKCSGDGVGA | 6 | O15355 | |
| NGVINTPELNCKGNG | 1771 | Q8IVL1 | |
| ELNASAPNDGLCQGG | 226 | Q9H2Y9 | |
| APNDGLCQGGNSTAT | 231 | Q9H2Y9 | |
| GGENSPCNVVSKQPG | 106 | O00161 | |
| VPEASGPQNDGKQLC | 126 | Q99909 | |
| GLGCAPSAGSRQKQE | 536 | Q8IUH8 | |
| TGQTGNCESPLGSKE | 371 | Q9P2F8 | |
| CGQGLPAPNNSIQGK | 636 | Q2M3G4 | |
| EEASRQPCGQQLSGG | 856 | Q8TF72 | |
| GTGKLGNLTAPCNEK | 491 | Q86UG4 | |
| AGPIGNATGQADCKA | 51 | Q8NBI5 | |
| QKDPLLCGNGSDAGQ | 331 | Q9NY46 | |
| GNSSAVLGLCDKGPD | 491 | P46721 | |
| GAGVLLSQDCAGTPQ | 331 | Q01113 | |
| GNSSELGVFQGPDLC | 166 | Q9NZ20 | |
| CDPNKVNPGSSVKGD | 1741 | P35498 | |
| SKDIGNVPGNCSENP | 1301 | Q8TER0 | |
| SPVGCVNGKVGDLNS | 1431 | Q13023 | |
| TDCNVLLGAPTGSGK | 1341 | Q8N3C0 | |
| SEGQDKGCRGTLPAQ | 541 | Q6ZRI6 | |
| GKEIDPANGCTSRGQ | 251 | O75443 | |
| AQGPGSGEACVENGK | 226 | Q92618 | |
| IGKPGGSLDNSEQKC | 51 | Q9Y5L4 | |
| SPDNVPLKGGNCSED | 71 | P32971 | |
| NNPGGRECIKGVNAE | 76 | Q6PDB4 | |
| NGSVVPNCDISNGGS | 626 | Q6NZY4 | |
| LEASQVGSGKAGPCT | 136 | Q8N377 | |
| QGNVDSCQGDSGGPL | 431 | O15393 | |
| SCQGDSGGPLVTSKN | 436 | O15393 | |
| QPGQSGLCGVAAAAT | 516 | Q6AWC2 | |
| PCAVSAGRSKGNGLQ | 231 | Q15697 | |
| DGGSQGPLCSLDSNL | 166 | Q9NZQ8 | |
| GGHKNTGNVQDPGVC | 841 | A0A1B0GUW6 | |
| KGSAGAPSVENVKNG | 86 | P35813 | |
| VPEASGPQNDGKQLC | 126 | O60224 | |
| VPEASGLQNDGKQLC | 126 | Q7RTT3 | |
| QQQCGGGGATKPAVS | 26 | Q5VTL8 | |
| NGLCLSKGNPECDGK | 576 | Q9Y5Y6 | |
| SPLEKCLGSANGNGD | 16 | Q5VUG0 | |
| IGGINCANGKPLSQE | 276 | P35504 | |
| LDGKVDSCQGDSGGP | 376 | Q7Z410 | |
| LEGKVDSCQGDSGGP | 676 | Q7Z410 | |
| SSQKNGCQLGEPRGP | 111 | Q9UJ04 | |
| KNSEVVAGTGDQCLP | 1316 | Q6N022 | |
| CGDGGKATEATLTNP | 1336 | Q6N022 | |
| NGFVGDGISTCNGKL | 2311 | Q9NY15 | |
| SSNCENGSPQKGRGG | 41 | O43680 | |
| PSCNGQADGNKLLAP | 1161 | Q9P273 | |
| GGVLAGALCNSNPEL | 561 | Q4J6C6 | |
| CGQGEEKSEGPLGSQ | 2281 | P08922 | |
| CQGDSGGPVVSNGEL | 196 | P07478 | |
| NQDGLPGCSLIQGFT | 3466 | Q86WI1 | |
| NVCSPGSQSGAAKDG | 466 | Q6AHZ1 | |
| LGQGQEGQPEARACS | 6 | H0YL09 | |
| GGNILDTGAGDPSCK | 136 | Q9BZ71 | |
| CASSLNGGNIKGIEG | 276 | Q96GY0 | |
| GAGQGSNGASVKCPV | 21 | Q5T750 | |
| LGSNAGNKPCKNQLG | 96 | Q3MIS6 | |
| VDCADKSQPGGQEGV | 806 | Q96DT7 | |
| DGSSPGNTGKENCEA | 241 | Q8NAP3 | |
| QELSQSKTGGECGNG | 71 | Q8WTP9 | |
| AGPQGKATQACGHQL | 321 | Q53SZ7 | |
| EGAQDCKFPGNTGRQ | 106 | Q6XPR3 | |
| GFQNPTAKECEGLAT | 791 | Q5VYS8 | |
| CQVGLQEGPDGENSS | 336 | Q8IWV8 | |
| AECNGLQPLVDQDGG | 306 | Q9Y6X0 | |
| CGGGENTSKSAEEPV | 241 | Q8NG27 | |
| ISACGPGAQEGTAEQ | 6 | Q6NT89 | |
| APLNGGAFCEGQSVQ | 291 | O95185 | |
| DFKGQPGICGLTNLG | 301 | P51784 | |
| SGCALTDAVAPGNKG | 81 | Q9BQ70 | |
| KGPVGSGSSGINIQC | 381 | Q8NDV7 | |
| GDKCSGPNGQANGDT | 531 | Q8NDV7 | |
| PCGTEKNFTNGMVNG | 846 | P35125 | |
| EDNKTGPCSNGKAAS | 96 | A6NL46 | |
| QQGDARGSPKQDSPC | 151 | Q9HCK0 | |
| DQCGKGFIEGPSLTQ | 281 | Q99676 | |
| IGGINCANGKPLSQE | 276 | P22310 | |
| TLLQPDENICSAGGG | 701 | Q8WXR4 |